CDC panel votes to resume use of J&J COVID vaccine without restrictions
The committee said the link between blood clots and J&J’s COVID vaccine was 'plausible,' but concluded the vaccine’s benefits still outweigh the risks and recommended the vaccine for persons 18 years of age and older in the U.S. under the FDA’s Emergency Use Authorization.
•